Agenus to Present at the American Society of Clinical Oncology 2023 Annual Meeting

Author's Avatar
Apr 26, 2023

Agenus (Nasdaq: AGEN), a leading immuno-oncology company specializing in immunological agents for cancer and infectious diseases, today announced plans to present clinical data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting, to be held June 2-6 in Chicago, IL.